The Indian Journal of Pediatrics

, Volume 54, Issue 3, pp 303–310 | Cite as

Congenital adrenal hyperplasia: basic physiology, clinical presentation and management

  • Nancy G. Greger
  • Surendra K. Varma
Special Article


DHEA Congenital Adrenal Hyperplasia Mineralocorticoid Pregnenolone Zona Glomerulosa 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Dexter RN, Fishman LM, Ney RL, Liddle GW. An effect of adrenocorticotrophic hormone on adrenal cholesterol accumulation.Endocrinology 1967;81: 1185–1187PubMedGoogle Scholar
  2. 2.
    Stone D, Hechter O. Studies on ACTH action in perfused bovine adrenals: Aspects of progesterone as an intermediary in corticosteroidogenesis.Arch Biochem Biophys 1955;54: 121–128CrossRefGoogle Scholar
  3. 3.
    Kimura T. ACTH stimulation on cholesterol side chain cleavage activity of adrenocortical mitochondria.Mol Cell Biochem 1981;36: 105–122PubMedCrossRefGoogle Scholar
  4. 4.
    Matteson KJ, Chung B, Urdea MS, Miller WL. Study of cholesterol side-chain cleavage (20, 22 desmolase) deficiency causing congenital lipoid adrenal hyperplasia using bovine sequence P450 scc oligodeoxyribonucleotide probes.Endocrinology 1986;118: 1296–1305PubMedGoogle Scholar
  5. 5.
    Lieberman S, Greenfield NJ, Wolfson A. A heuristic proposal for understanding steroidogenic process.Endocrine Reviews 1984;5: 128–148PubMedGoogle Scholar
  6. 6.
    Kuhnle U, Chow D, Rapaport R, Pang S, Levine LS, New MI. The 21-hydroxylase activity in the glomerulosa and fasciculata of the adrenal cortex in congenital adrenal hyperplasia.J Clin Endocrinol Metab 1981;52: 534–544PubMedGoogle Scholar
  7. 7.
    New MI, Dupont B, Pang S, Pollack M, Levine LS. An update of congenital adrenal hyperplasia.Recent Progr Horm Res 1981;37: 105–181PubMedGoogle Scholar
  8. 8.
    Kohn B, Levine LS, Pollack MSet al. Lateonset steroid 21-hydroxylase deficiency: A variant of classical congenital adrenal hyperplasia.J Clin Endocrinol Metab 1982;55: 817–826PubMedGoogle Scholar
  9. 9.
    New MI, Lorenzeu F, Lerner AJ, et al. Genotyping steroid 21-hydroxylase deficiency: Hormonal reference data.J Clin Endocrinol Metab 1983;57: 320–326PubMedGoogle Scholar
  10. 10.
    New MI, Levine LS. Congenital adrenal hyperplasia.Monographs on Endocrinology, Vol. 26. Berlin: Springer-Verlag 1984; p 44Google Scholar
  11. 11.
    Hirschfeld AJ, Fleshman JK. An unusually high incidence of salt-losing congenital adrenal hyperplasia in the Alaskan Eskimo.J Pediatr 1969;75: 492–494PubMedCrossRefGoogle Scholar
  12. 12.
    Pang S, Hotchkiss J, Drash A, Levine L, New MI. Microfilter paper method for 17 α-hydroxyprogesterone radioimmunoassay: Its application for rapid screening for congenital adrenal hyperplasia.J Clin Endocrinol Metab 1977;45: 1003–1008PubMedGoogle Scholar
  13. 13.
    Pang S, Murphey W, Levine LSet al. A pilot newborn screening for congenital adrenal hyperplasia in Alaska.J Clin Endocrinol Metab 1982;55: 413–420PubMedGoogle Scholar
  14. 14.
    Hofman LF, Klaniecki JE, Smith EK. Direct solid phase radioimmunoassay for screening 17 α-hydropcyprogesterone in whole blood samples from newborns.Clin Chem 1985;31: 1127–1130PubMedGoogle Scholar
  15. 15.
    Shimozawa K, Yata J, Kitagawa T,et al. A neonatal mass screening for congenital adrenal hyperplasia by fluorescence enzyme immunoassay methods.Pediatrics 1985;19: 621Google Scholar
  16. 16.
    Pang S, Pollack MS, Loo M,et al. Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia.J Clin Endocrinol Metab 1985;61: 89–97PubMedCrossRefGoogle Scholar
  17. 17.
    David M, Forest MG. Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency.J Pediatr 1984;105: 799–803PubMedCrossRefGoogle Scholar
  18. 18.
    Holcombe JH, Keenan BS, Nichols BL, Kirkland RT, Clayton GW. Neonatal salt loss in the hypertensive form of congenital adrenal hyperplasia.Pediatrics 1980;65: 777–781PubMedGoogle Scholar
  19. 19.
    Zachmann M, Tassinari D, Prader A. Clinical and biochemical variability of congenital adrenal hyperplasia due to 11-β hydroxylase deficiency. A study of 25 patients.J Clin Endocrinol Metab 1983;56: 222–228PubMedGoogle Scholar
  20. 20.
    Zadik Z, Kahana L, Kaufman H, Benderli A, Hochberg Z. Salt loss in hypertensive form of congenital adrenal hyperplasia (11-β hydroxylase deficiency).J Clin Endocrinol Metab 1984;58: 384–387PubMedGoogle Scholar
  21. 21.
    Prader A, Gurtner HP. Das syndrom des pseudohermaphroditismus masculinus bef kongenitaler nebennierenrinden hyperplasie ohne adrogenuberproduktion.Helv Paediatr Acta 1955;10: 397–412PubMedGoogle Scholar
  22. 22.
    Bongiovanni AM. The adrenogenital syndrome with deficiency of 3β hydroxysteroid dehydrogenase.J Clin Invest 1962;41: 2086–2092PubMedCrossRefGoogle Scholar
  23. 23.
    Pang S, Levine LS, Stoner E, Opitz JM, Pollack MS, Dupont B, New MI. Nonsaltlosing congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function.J Clin Endocrinol Metab 1983;56: 808–818PubMedGoogle Scholar
  24. 24.
    Cara JF, Moshang T, Bongiovanni AM, Marx BS. Elevated 17 α-hydroxyprogesterone and testosterone in a newborn with 3-beta-hydroxy-steroid dehydrogenase deficiency.N Engl J Med 1985;313: 618–621PubMedCrossRefGoogle Scholar
  25. 25.
    Biglieri EG, Herron MA, Brust N. 17-hydroxylation deficiency in man.J Clin Invest 1966:45: 1946–1954PubMedGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 1987

Authors and Affiliations

  • Nancy G. Greger
    • 1
    • 2
  • Surendra K. Varma
    • 1
    • 2
  1. 1.School of Medicine, Department of PediatricsTexas Tech UniversityEl PasoU.S.A.
  2. 2.School of Medicine, Department of PediatricsTexas Tech UniversityLubbockU.S.A.

Personalised recommendations